Lexaria Bioscience Corp. (OTCQX: LXRP; CSE: LXX; the
"Company" or "Lexaria"), a drug delivery platform
innovator, and Hill Street Beverage Company Inc., (TSXV:BEER; "Hill
Street") jointly announced that they have signed a Definitive Agreement to
license Lexaria's DehydraTECHTM, on a semi-exclusive basis, for a term of five
(5) years, to produce a line of cannabis-infused alcohol-free beverages for
Canadian distribution, following regulatory approval. The Definitive Agreement
is the conclusion of the process begun following the announcement of the
non-binding letter of intent in April 2018. Terms of the Definitive Agreement
were not disclosed.
"Company" or "Lexaria"), a drug delivery platform
innovator, and Hill Street Beverage Company Inc., (TSXV:BEER; "Hill
Street") jointly announced that they have signed a Definitive Agreement to
license Lexaria's DehydraTECHTM, on a semi-exclusive basis, for a term of five
(5) years, to produce a line of cannabis-infused alcohol-free beverages for
Canadian distribution, following regulatory approval. The Definitive Agreement
is the conclusion of the process begun following the announcement of the
non-binding letter of intent in April 2018. Terms of the Definitive Agreement
were not disclosed.
No comments:
Post a Comment